BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34913590)

  • 41. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skeletal staging in Langerhans cell histiocytosis: a multimodality imaging review.
    Rajakulasingam R; Siddiqui M; Michelagnoli M; Saifuddin A
    Skeletal Radiol; 2021 Jun; 50(6):1081-1093. PubMed ID: 33215231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical utility of fluorodeoxyglucose-positron emission tomography for investigation of fever in immunocompromised children.
    Wang SS; Mechinaud F; Thursky K; Cain T; Lau E; Haeusler GM
    J Paediatr Child Health; 2018 May; 54(5):487-492. PubMed ID: 29235187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
    Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
    Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncologic
    Montilla-Soler JL; Makanji RJ; Barron BJ
    Am J Med; 2018 Apr; 131(4):357-364. PubMed ID: 29274757
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET with
    Harrison DJ; Parisi MT; Khalatbari H; Shulkin BL
    PET Clin; 2020 Jul; 15(3):333-347. PubMed ID: 32498989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis.
    Calming U; Bemstrand C; Mosskin M; Elander SS; Ingvar M; Henter JI
    J Pediatr; 2002 Sep; 141(3):435-40. PubMed ID: 12219070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of
    Narayanan P; Sahdev A
    Br J Radiol; 2017 Nov; 90(1079):20170283. PubMed ID: 28830238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Value of
    Hynninen J; Laasik M; Vallius T; Kemppainen J; Grönroos S; Virtanen J; Casado J; Hautaniemi S; Grenman S; Seppänen M; Auranen A
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):507-514. PubMed ID: 29753662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advantages of
    Németh Z; Boér K; Borbély K
    Pathol Oncol Res; 2019 Jan; 25(1):131-136. PubMed ID: 28994004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
    Kitajima K; Miyoshi Y
    Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical
    Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
    Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging features of
    Chen Z; Zhao Y; Wang Q; Li Y; Li H; Zhou Y
    Clin Rheumatol; 2022 May; 41(5):1499-1509. PubMed ID: 35088208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Musculoskeletal Pitfalls on Fluorodeoxyglucose F 18 PET-Computed Tomography: Pictorial Review.
    Asadoorian M; Matcuk GR; Patel DB; Tomasian A; Wassef HR; White EA
    PET Clin; 2018 Oct; 13(4):587-607. PubMed ID: 30219190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.